肾安汤加减治疗持续性不卧床腹膜透析患者营养不良状态临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R692

基金项目:

佛山市科技创新项目(2020001005156)


Clinical Study on Modified Shen'an Decoction for Improving Malnutrition in Patients with Continuous Ambulatory Peritoneal Dialysis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察肾安汤加减治疗对持续性不卧床腹膜透析(CAPD) 脾肾气虚夹湿浊证患者营养不良状 态的改善效果。方法:选取2023年2—12月于广州中医药大学顺德医院肾内科就诊的68例CAPD脾肾气虚夹湿 浊证患者,根据随机数字表法分为治疗组与对照组各34例。对照组予西医基础治疗方案治疗,治疗组在对照 组基础上予肾安汤加减治疗,2组均治疗12周。治疗12周后评估2组临床疗效。比较2组治疗前后中医证候积 分、主观综合营养评估法(SGA) 评分、营养不良-微炎症(MIS) 评分、营养指标[白蛋白(Alb)、前白蛋 白(PA)、铁蛋白(SF)、血红蛋白(Hb)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)]、微炎症指标 [超敏C-反应蛋白(hs-CRP)] 及肾功能指标[血肌酐(SCr)、血尿素氮(BUN)]。治疗期间记录2组不良 反应发生率。结果:治疗后,2组倦怠乏力、少气懒言、食少纳呆、腰膝酸软、恶心、肢体困重、脘腹胀满、 大便不实、口淡不渴、口中黏腻、夜尿频多积分,中医证候总分,以及治疗组水肿积分均较治疗前降低(P< 0.05),治疗组倦怠乏力、少气懒言、腰膝酸软、脘腹胀满、水肿积分及中医证候总分均较对照组降低更明 显(P<0.05)。治疗组中医证候疗效总有效率86.67% (26/30),高于对照组56.67% (17/30)(P<0.05)。2组 SGA、MIS评分均较治疗前降低(P<0.05),治疗组SGA、MIS评分均较对照组降低更明显(P<0.05)。治疗组 Alb、Hb水平均较治疗前升高,且均高于对照组(P<0.05)。2组hs-CRP水平及治疗组SCr、BUN水平均较治 疗前降低(P<0.05),治疗组BUN水平低于对照组(P<0.05)。治疗组不良反应发生率20.00%(6/30),对照 组不良反应发生率30.00%(9/30),2组比较,差异无统计学意义(P>0.05)。结论:在西医疗法基础上加用肾 安汤加减治疗能有效改善CAPD脾肾气虚夹湿浊证患者的营养状态,缓解临床症状,且安全性良好。

    Abstract:

    Abstract:Objective:To observe the effect of modified Shen´an Decoction on improving malnutrition in patients with continuous ambulatory peritoneal dialysis (CAPD) who have spleen-kidney qi deficiency with damp-turbidity syndrome. Methods: A total of 68 CAPD patients with spleen-kidney qi deficiency and damp-turbidity syndrome, treated at the Nephrology Department of Shunde Hospital of Guangzhou University of Chinese Medicine,from February to December 2023,were selected and divided into the treatment group and the control group according to the random number table method,with 34 cases in each group. The control group was given standard western medical treatment, and the treatment group was additionally treated with modified Shen´an Decoction based on the treatment of the control group. Both groups were treated for 12 weeks. Clinical effects were assessed after 12 weeks of treatment. Traditional Chinese medicine syndrome scores, Subjective Global Assessment (SGA) scores, Malnutrition Inflammation Score (MIS), nutritional indicators [albumin (Alb), prealbumin (PA), serum ferritin (SF), hemoglobin (Hb), total cholesterol (TC),low-density lipoprotein cholesterol (LDL-C)],microinflammation indicators [high-sensitivity C-reactive protein (hs-CRP)],and kidney function indicators [serum creatinine (SCr),blood urea nitrogen (BUN)] were compared before and after treatment in the two groups. The incidence of adverse reactions in the two groups was recorded during the treatment period. Results:After treatment,scores for fatigue and lack of strength,lack of qi and lazy speech, poor appetite, weakness in the lower back and knees, nausea, heaviness in the limbs, abdominal distension,loose stools,bland taste,sticky mouth,and frequent nocturnal urination,as well as the total traditional Chinese medicine syndrome scores in the two groups were significantly decreased when compared with those before treatment,and the edema score in the treatment group was decreased when compared with that before treatment (P< 0.05);the decrease in the scores of fatigue and lack of strength,lack of qi and lazy speech,weakness in the lower back and knees,abdominal distension,edema,and total traditional Chinese medicine scores in the treatment group was more significant compared to the control group (P<0.05). The overall effective rate of traditional Chinese medicine syndrome in the treatment group was 86.67% (26/30),higher than 56.67% (17/30) in the control group (P<0.05). Both groups showed significant reductions in the scores of SGA and MIS compared to before treatment (P<0.05),with the treatment group showing more significant reductions than the control group (P<0.05). The levels of Alb and Hb in the treatment group were significantly increased when compared with those before treatment and higher than those in the control group (P<0.05). The levels of hs-CRP in the two groups and the levels of SCr and BUN in the treatment group were significantly reduced when compared with those before treatment (P<0.05), with BUN level in the treatment group being lower than that in the control group (P<0.05). The incidence of adverse reactions was 20.00% (6/30) in the treatment group and 30.00%( 9/30) in the control group,with no significant difference between the two groups( P> 0.05). Conclusion: The additional treatment of modified Shen´an Decoction based on standard western medical treatment can effectively improve the nutritional status of CAPD patients with spleen-kidney qi deficiency and dampturbidity syndrome and alleviate clinical symptoms,with good safety.

    参考文献
    相似文献
    引证文献
引用本文

张颖,孙季菡,梁谋.肾安汤加减治疗持续性不卧床腹膜透析患者营养不良状态临床研究[J].新中医,2025,57(10):49-55

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-05-27
  • 出版日期:
文章二维码